🇺🇸 FDA
Patent

US 8378084

Fusion molecule based on novel TAA variant

granted A61KA61K2039/55522A61K38/193

Quick answer

US patent 8378084 (Fusion molecule based on novel TAA variant) held by The Regents of the University of California expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/55522, A61K38/193, A61K40/11, A61K40/13